PRM (Perimeter Solutions, Inc.) Stock Analysis - News

Perimeter Solutions, Inc. (PRM) is a publicly traded Basic Materials sector company. As of May 21, 2026, PRM trades at $34.17 with a market cap of $5.45B and a P/E ratio of -24.84. PRM moved -0.84% today. Year to date, PRM is +20.76%; over the trailing twelve months it is +183.18%. Its 52-week range spans $8.76 to $34.89. Analyst consensus is buy with an average price target of $37.00. Rallies surfaces PRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in PRM news today?

Perimeter Solutions Q1 Sales Up 74% to $125.1M, EBITDA Jumps 128%: Perimeter Solutions posted Q1 2026 net sales of $125.1M, up 74% year-over-year, driven by 128% growth in Specialty Products ($79.6M) and 22% rise in Fire Safety ($45.5M), resulting in net income of $72.9M ($0.44 per diluted share) and Adjusted EBITDA of $41.2M (versus $18.1M). The company acquired Medical Manufacturing Technologies for $682.3M and secured five-year Defense Logistics Agency and California Department of Forestry contracts for suppressants and retardants in April.

PRM Key Metrics

Key financial metrics for PRM
MetricValue
Price$34.17
Market Cap$5.45B
P/E Ratio-24.84
EPS$-1.37
Dividend Yield0.00%
52-Week High$34.89
52-Week Low$8.76
Volume1.03M
Avg Volume0
Revenue (TTM)$652.86M
Net Income$-206.37M
Gross Margin57.46%

Latest PRM News

Recent PRM Insider Trades

  • Sable Kyle sold 46.26K (~$1.53M) on May 13, 2026.
  • Sable Kyle sold 3.28K (~$110.07K) on May 13, 2026.
  • Emery Jeffrey sold 53.54K (~$1.79M) on May 13, 2026.

PRM Analyst Consensus

2 analysts cover PRM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.00.

Common questions about PRM

What changed in PRM news today?
Perimeter Solutions Q1 Sales Up 74% to $125.1M, EBITDA Jumps 128%: Perimeter Solutions posted Q1 2026 net sales of $125.1M, up 74% year-over-year, driven by 128% growth in Specialty Products ($79.6M) and 22% rise in Fire Safety ($45.5M), resulting in net income of $72.9M ($0.44 per diluted share) and Adjusted EBITDA of $41.2M (versus $18.1M). The company acquired Medical Manufacturing Technologies for $682.3M and secured five-year Defense Logistics Agency and California Department of Forestry contracts for suppressants and retardants in April.
Does Rallies summarize PRM news?
Yes. Rallies summarizes PRM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PRM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRM. It does not provide personalized investment advice.
PRM

PRM